Elizabeth is an associate in Cooley’s global life sciences and healthcare regulatory practice, where she counsels pharmaceutical, biologic, medical device, digital health, food, dietary supplement and cosmetic companies on US Food and Drug Administration (FDA) regulatory compliance issues, such as research, development and commercialization issues, clinical trial conduct, and responding to FDA inspection observations. She advises on a wide range of contracts in the life sciences space, such as clinical trial agreements, contract research organization (CRO) agreements, pharmacovigilance agreements and quality agreements. She also routinely provides regulatory support for various corporate and licensing transactions. Elizabeth joined Cooley in 2024 from another international law firm, where she also worked on M&A transactions, licensing and collaboration deals, and royalty monetizations involving life sciences companies.